TL;DR
Oura has agreed to acquire Counsel Health for $625 million in an all-cash transaction, subject to adjustments, with closing expected before the end of 2026. The deal would bring Counsel’s AI-enabled medical guidance and physician access further into Oura’s health platform; the companies have not disclosed details such as how the service or its pricing may change after the acquisition.
Oura, the smart-ring maker, has agreed to acquire Counsel Health in an all-cash deal valued at $625 million, subject to adjustments. The companies said they expect the transaction to close before the end of 2026; the deal would give Oura a larger role in connecting wearable data with AI-supported medical guidance and access to physicians.
Get wellness gear delivered free with Prime
- Fast, free delivery on millions of items
- Prime Video, Amazon Music and more included
- Member-only deals all year
Counsel combines artificial intelligence with access to board-certified physicians. The companies already have a partnership, launched earlier in 2026, through which Oura members can seek medical guidance and physician care in the Oura app. The proposed acquisition would deepen that relationship and extend Oura’s presence from consumer health tracking into healthcare delivery.
Under the existing service, members can ask medical questions and receive responses informed by their health history and Oura data, including sleep, heart rate, activity and recovery metrics. If a user needs additional care, the service can connect them with a licensed physician. According to the source report, physicians may diagnose conditions, prescribe medication or recommend further testing.
The service is available through Oura Labs in 43 states and costs $159 a year, according to the report. Oura and Counsel plan to expand work across preventive and acute care and chronic condition management, with areas including reproductive health, aging and cardiometabolic conditions. The announcement does not specify whether the current price or availability will change after the deal closes.
Oura Adds Care Beyond Wearables
The acquisition would give Oura a path to connect information collected by its ring with medical guidance and clinician access. That could change the role of its app: instead of mainly presenting sleep, activity and recovery measures, it could also direct members toward care when they have health questions. The companies describe this as a planned expansion; the announcement does not establish how widely members will use the service or what clinical outcomes it may produce.
The transaction also has potential business implications. Oura’s model has relied mainly on ring sales and recurring memberships. Adding a medical service could create another reason for customers to stay engaged with the platform and may open routes into employer benefits or healthcare markets. Those are possible opportunities, not confirmed results: the companies have not disclosed financial targets, a post-acquisition business plan or details of any new employer offerings.
For users, the practical issue is how wearable information will inform the care they receive. Oura data can provide context about patterns such as sleep and activity, but the acquisition announcement does not say that ring measurements will replace clinical assessment. The service is described as combining AI with access to physicians, and the role of each in evaluating a particular concern will depend on the service’s clinical process.
Products Worth Considering
Garmin Forerunner® 165 Running Smartwatch 43mm Black
Philips Sonicare ProtectiveClean 5300 Rechargeable Electric Toothbrush with 3 Brush Heads, Black
Hyperice Hypervolt Go 3 Percussion Massage Gun with Carry Case
As an affiliate, we earn on qualifying purchases.
Oura’s Recent Healthcare Moves
The planned purchase follows several steps by Oura to bring biometric information into healthcare settings. In January, Oura partnered with Fullscript to make members’ sleep, readiness and activity trends available to clinicians, with user consent. The platform is used by more than 125,000 healthcare providers, according to the source report. In April, Oura partnered with Vida Health to add continuous biometric monitoring to clinician-led metabolic care programs.
Oura has also added health features to its own products. The report says the company introduced Health Records, GLP-1 Insights, laboratory result uploads and preventive health monitoring with the launch of Oura Ring 5 in May. The Counsel acquisition would build on these efforts by adding an existing service that combines AI-generated guidance with physician access, rather than relying only on data display or clinician-facing integrations.
The deal comes as Oura reports growth. The company reported preliminary fiscal 2026 revenue of about $1.75 billion, up 92% year over year, and more than six million members, according to the report. It also said Oura had reportedly been preparing for an initial public offering in the fall but postponed it in September amid market uncertainty. Those figures and the IPO account are background to the deal; the companies have not said the acquisition is tied to a revised public-market timetable.
“Oura tells members what’s happening in their bodies, and Counsel helps them act on it.”
— David Shuman, Oura’s executive chairman
Deal Terms and Service Changes
The announced $625 million value is subject to adjustments, and the companies have not provided a final closing date beyond saying they expect to complete the deal before the end of 2026. The source report describes the transaction as all cash, but does not give further detail on the adjustment mechanism or whether regulatory or other conditions could affect the timetable.
It is also unclear what will happen to the $159 annual subscription, Oura Labs availability in 43 states, or the current partnership’s service terms after closing. The announcement does not outline plans for geographic expansion, new prices, staffing or how Counsel’s physicians and AI will be integrated into Oura’s wider product. The companies have not provided information on how user health data will be handled under the combined business beyond the existing account of using members’ health history and Oura data in the service.
The companies’ plans to expand into reproductive health, aging and cardiometabolic care are stated intentions, not a schedule of launched services. The announcement also provides no evidence about clinical effectiveness or how the service will measure outcomes. Those details remain open as the transaction proceeds.
Closing Expected by Year-End
Oura and Counsel expect the acquisition to close before the end of 2026. Until then, the companies’ existing service remains the basis for members’ access to AI-supported medical guidance and physicians, as described in the source report. Any updates to availability, pricing or care offerings have not yet been announced.
Readers should look for further information from the companies on the final deal terms, the closing date and how Counsel will operate within Oura. The next substantive milestones are the transaction’s completion and details of how the planned expansion into preventive, acute and chronic care will be put into practice.
Key Questions
What has Oura agreed to acquire?
Oura has agreed to acquire Counsel Health, an AI-enabled primary care company that combines medical AI with access to board-certified physicians.
How much is the deal worth?
The transaction is valued at $625 million and is described as all cash, subject to adjustments.
When is the acquisition expected to close?
The companies expect the deal to close before the end of 2026. They have not announced a specific closing date.
What does Counsel offer Oura members now?
Through the existing Oura Labs service, members can ask medical questions informed by their health history and Oura data, and can connect with a licensed physician when additional care is needed. The report says it is available in 43 states for $159 a year.
Will the acquisition change the service price or availability?
The companies have not said whether the current price, state availability or service terms will change after the acquisition closes.
Source: athletechnews.com
